BHC
$23.73
Bausch Health Companies
$.27
1.15%
BHC
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  $1.09
Revenue:  $2.75 Bil
Tuesday
Feb 1
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BHC reports earnings?
Beat
Meet
Miss

Where is BHC's stock price going from here?
Up
Flat
Down
Stock chart of BHC
Analysts
Summary of analysts' recommendations for BHC
Score
Grade
Pivots
Resistance
$25.41
$24.85
$24.29

$23.73

Support
$23.17
$22.61
$22.05
Tweet
Growth
Description
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.